2023年7月6日

以色列启动,筹集了8500万美元主要来自创始人马吕斯纳赫特,员工减少了超过75%在过去的一年里,希望其技术卖给另一家公司索菲舒尔曼buzz和炒作后,以色列营养公司DayTwo即将结束的旅程。公司共同创立,主要由马吕斯纳赫特,减少它的大部分业务,只保留一个小的核心团队开发和客户服务在以色列和美国据Calcalist来源。目的是支持现有的客户和潜在的技术卖给外部。在2022年该公司雇佣了150名员工,但现在只有35名员工剩余的,与在美国20在以色列和15(照片:奥廖尔Cohen) DayTwo筹集了8500万美元来开发和市场工具,个性化的营养对于糖尿病患者根据自己的粪便样本。公司的独特方法意味着它有时会推荐的食物,比如披萨,汉堡和薯条,面包与黄油,它认为可能对某些人更健康。通过基因分析和糖测试,系统提供个性化调整食物的选择。虽然DayTwo展示积极的结果在改善血糖水平,减肥的结果是不确定的。批评也出现在食物的建议,尽管他们sugar-lowering好处,被认为不健康。尽管最初的热情和营销通过以色列参加hmo Clalit,收取一次性支付工具,该公司的商业模式无法产生利润。两年前,首席执行官Lihi Segal,创始人之一,离开了,戴夫·亨德森,美国首席执行官。 The plan was to enter the U.S. market and adopt a subscription model with organizations and insurance companies, some of which signed agreements with the company. However, the emergence of diabetes injections like Ozempic, which offer both sugar level management and weight loss benefits, undermined DayTwo's target population. Starting in 2023, cooperation between DayTwo and Maccabi and Clalit came to an end and it is no longer possible to order new kits. Only support for existing customers is provided. Calcalist also discovered that the company recently sold its laboratory and shifted operations to the U.S. through distributors. At the end of 2022, a significant downsizing took place, resulting in the dismissal of dozens of employees in both Israel and the U.S. DayTwo conducted further layoffs in recent weeks, including senior personnel. Related articles: